Veracyte Inc.
Organization details
- Legal name
- Veracyte Inc.
- Former names
- Calderome Inc
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- South SAN Francisco
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- VCYT
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001384101
- EIN
- 20-5455398
Board of directors
-
Bonnie H. Anderson · DirectorSince 2023
-
David Brent Shafer · DirectorSince 2024
-
Eliav Barr · DirectorSince 2023
-
Evan/ Fa Jones · DirectorSince 2023
-
Jens Holstein · DirectorSince 2023
-
John L. Bishop · DirectorSince 2023
-
Karin Eastham · DirectorSince 2023
-
Marc Stapley · Director · Chief Executive OfficerSince 2023
-
Muna Bhanji · DirectorSince 2023
-
Robert S. Epstein · DirectorSince 2023
-
Thomas F. Miller · DirectorSince 2024
Chief executives
Director election results
Annual meeting of June 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
93.1%
-
96.6%
-
97.0%
-
98.4%
-
98.7%
-
99.8%
-
99.8%
-
99.9%
Board connections
7 of this board's directors also sit on 12 other boards. 10 are in the same sector.
-
Ardelyx Inc. Same sectorvia Muna Bhanji
-
Baxter International Inc. Same sectorvia David Brent Shafer
- via Bonnie H. Anderson
-
Cytokinetics Incorporated Same sectorvia Muna Bhanji
-
Fate Therapeutics Inc. Same sectorvia Robert S. Epstein
-
Geron Corporation Same sectorvia Karin Eastham
-
Glaukos Corporation Same sectorvia Marc Stapley
-
Iambic Therapeutics Inc. Same sectorvia Thomas F. Miller
- via Robert S. Epstein
-
Intellia Therapeutics Inc. Same sectorvia Muna Bhanji
-
Personalis Inc. Same sectorvia Karin Eastham
-
Tactile Systems Technology Inc. Same sectorvia David Brent Shafer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $19,248,658
- 50 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 28, 2026 | Wygant Jonathan Officer (VP, Chief Accounting Officer) | Shares withheld for tax | −1,306 | $50.31 | $65,705 |
| Oct 27, 2026 | Karin Eastham Director | Option exercise | +10,000 | $27.01 | $270,100 |
| Oct 27, 2026 | Karin Eastham Director | Open-market sale | −14,850 | $50.00 | $742,573 |
| Oct 27, 2026 | Jens Holstein Director | Option exercise | +7,500 | $35.30 | $264,750 |
| Oct 27, 2026 | Jens Holstein Director | Open-market sale | −7,500 | $50.00 | $375,000 |
| Oct 19, 2026 | Muna Bhanji Director | Open-market sale | −1,864 | $43.70 | $81,457 |
| Sep 24, 2026 | Jens Holstein Director | Option exercise | +7,500 | $35.30 | $264,750 |
| Sep 24, 2026 | Jens Holstein Director | Open-market sale | −7,500 | $47.00 | $352,500 |
| Sep 21, 2026 | Leite John Officer (Global Chief Commercial Off) | Open-market sale | −4,015 | $40.00 | $160,600 |
| Sep 14, 2026 | Jens Holstein Director | Open-market sale | −5,000 | $40.95 | $204,750 |
| Sep 4, 2026 | Rebecca Chambers Officer (Chief Financial Officer) | Open-market sale | −2,477 | $42.81 | $106,040 |
| Sep 4, 2026 | Febbo Phillip G. Officer (Chief Scientific & Med Officer) | Open-market sale | −10,405 | $42.89 | $446,270 |
| Sep 4, 2026 | McGuire Annie Officer (EVP, General Counsel) | Open-market sale | −2,154 | $42.79 | $92,170 |
| Sep 4, 2026 | Rebecca Chambers Officer (Chief Financial Officer) | Open-market sale | −1,175 | $43.71 | $51,359 |
| Sep 4, 2026 | Febbo Phillip G. Officer (Chief Scientific & Med Officer) | Open-market sale | −2,705 | $43.66 | $118,100 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Veracyte Inc.
Who is the CEO of Veracyte Inc.?
Marc Stapley is Veracyte Inc.'s Chief Executive Officer.
How many directors are on Veracyte Inc.'s board?
Veracyte Inc.'s board has 11 directors: Bonnie H. Anderson, David Brent Shafer, Eliav Barr, Evan/ Fa Jones, Jens Holstein, John L. Bishop, Karin Eastham, Marc Stapley, Muna Bhanji, Robert S. Epstein and 1 other.
Are Veracyte Inc. insiders buying or selling shares?
Over the last 12 months, Veracyte Inc. insiders made no open-market purchases and sold $19.2 million of shares in 50 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="veracyte-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.